Results
The eRulemaking Program
09/23/2024 | Press release | Distributed by Public on 09/23/2024 07:27
Filing of Petition: Color Additive; DSM Biomedical
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 74
[Docket No. FDA-2024-C-4339]
DSM Biomedical; Filing of Color Additive Petition
Agency
Food and Drug Administration, HHS.
Action
Notification of petition.
Summary
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by DSM Biomedical, proposing that the color additive regulations be amended to provide for the safe use of phthalocyanine green to color surgical sutures made of ultra-high molecular weight polyethylene (UHMWPE) for use in general surgery, at a concentration of no more than 0.5 percent by weight of the suture.
Dates
The color additive petition was filed on August 15, 2024.
Addresses
For access to the docket to read background documents or comments received, go to https://www.regulations.gov and insert the docket number found in brackets in the heading of this document into the "Search" box and follow the prompts, and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For Further Information Contact
Stephen DiFranco, Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-2710.
Supplementary Information
Under the Federal Food, Drug, and Cosmetic Act (section 721(d)(1) (21 U.S.C. 379e(d)(1))), we are giving notice that we have filed a color additive petition (CAP 4C0335), submitted by DSM Biomedical, 735 Pennsylvania Dr., Exton, PA 19341. The petition proposes to amend the color additive regulations in 21 CFR part 74, "Listing of Color Additives Subject to Certification," to provide for the safe use of phthalocyanine green to color surgical sutures made of UHMWPE for use in general surgery, at a concentration of no more than 0.5 percent by weight of the suture.
The petitioner claims that this action is categorically excluded under 21 CFR 25.32(l) because the substance is used in sutures. If FDA determines a categorical exclusion applies, neither an environmental assessment nor an environmental impact statement is required. If FDA determines a categorical exclusion does not apply, we will request an environmental assessment and make it available for public inspection.
Dated: September 18, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-21684 Filed 9-20-24; 8:45 am]
BILLING CODE 4164-01-P